Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Incipiam Pharma ApS
APS
Active
Reklamebeskyttelse
CVR 44074214
Ottiliavej 9, 2500
Valby
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 3 years old
2 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Incipiam Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
-1M
2025
EBITDA
DKK millions
0M
-1M
-1M
-2M
-3M
0M
2023
0M
0%
2024
-2M
-200%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Gross profit
-13
-98
-1.201
Staff expenses
-0
-30
-753
EBITDA
-13
-128
-1.954
Depreciation & amort.
-0
-0
-0
EBIT
-13
-128
-1.954
Net financials
0
0
-448
Profit before tax
-13
-128
-2.402
Tax
-0
-0
-554
Net profit
-13
-128
-1.847
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
27
4.472
8.795
Equity
27
-101
-1.949
Long-term debt
0
0
8.526
Short-term debt
0
4.574
2.218
Total debt
0
4.574
10.744
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-195391900.0%
This company
2023
2025
Soliditetsgrad
-22.2%
This company
38.2%
Market median
-158% vs market
2023
2025
Egenkapitalforrentning
-184735800.0%
This company
18.4%
Market median
-1003999013% vs market
2023
2025
Nettoresultatgrad (af bruttofortjeneste)
-184735800.0%
This company
2023
2025
Aktivomsætning (af bruttofortjeneste)
-0.14×
This company
2023
2025
Gæld/egenkapital
5.51×
This company
0.62×
Market median
-789% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-05-23 – 2023-12-31
View
PDF
More on Incipiam Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
